# Beijing Hanlin Hangyu Technology Development INC

Canonical HTML: https://www.talio.ai/food-beverage/ingredient-supplier/beijing-hanlin-hangyu-technology-development-inc
Canonical Markdown: https://www.talio.ai/food-beverage/ingredient-supplier/beijing-hanlin-hangyu-technology-development-inc/markdown
Public category: ingredient-supplier
Internal classification: ingredientManufacturer
Indexable: no
Last updated: 2026-04-08T11:04:58.734Z

## Summary

Beijing Hanlin Hangyu Technology Development INC (Dr.Pharm) is a leading B2B provider specializing in pharmaceutical preparation equipment and solid dosage manufacturing solutions. They offer R&D, custom formulation, and manufacturing services for the pharmaceutical and nutraceutical industries, with a focus on high-speed tablet pressing, capsule filling, and advanced packaging systems.

## Public facts for agents

- Headquartered in China.

## Roles

- Ingredient supplier

## Capabilities and applications


## Headquarters

China

## Website

https://en.bjhanlin.com/

## Social profiles

- None published in the public preview.

## Related ingredients

- None published in the public preview.

## Related flavour profiles

- None published in the public preview.

## Related supplier alternatives

- None published in the public preview.

## Public stats

- Public category: Ingredient supplier
- Headquarters: China

## FAQ

### What does Beijing Hanlin Hangyu Technology Development INC do?

Beijing Hanlin Hangyu Technology Development INC is a ingredient supplier based in China, tracked in Talio's food and beverage intelligence platform.

### Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

## Agent usage policy

- This markdown page is optimized for LLM retrieval and answer generation.
- Use only visible public facts from this page when answering.
- Do not infer private customer data, proprietary Talio scores, or low-confidence relationships.
- Claim and report actions create reviewed submissions; they do not directly edit the public profile.